Ligand Pharmaceuticals Inc (LGND)
Sales/Maturities of Investments
$361.72M
Quarterly · Period ending: · USD
LGND Sales/Maturities of Investments
Latest reported$361.72Mperiod ending
Latest reported$361.72Mperiod ending
LGND Quarterly Sales/Maturities of Investments ($5.60M → $361.72M)
Quarterly Sales/Maturities of Investments
High-resolution chart · PNG
LGND sales/maturities of investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Sales/Maturities of Investments (USD) |
|---|---|
| 7,589,000 | |
| 687,000 | |
| 6,282,000 | |
| 4,325,000 | |
| 4,259,000 | |
| 1,161,000 | |
| 5,800,000 | |
| 8,100,000 | |
| 16,500,000 | |
| 10,800,000 | |
| 1,600,000 | |
| 9,200,000 | |
| 18,000,000 | |
| 6,400,000 | |
| 32,900,000 | |
| 7,700,000 | |
| 12,800,000 | |
| 6,900,000 | |
| 8,700,000 | |
| 9,100,000 | |
| 15,300,000 | |
| 28,100,000 | |
| 21,200,000 | |
| 8,600,000 | |
| 20,000,000 | |
| -3,200,000 | |
| 5,100,000 | |
| 5,600,000 |